Quantcast

DrugRisk Update: Yaz Lawsuits Spread to Europe As Settlements Continue in U.S.

January 24, 2013

The DrugRisk Resource Center is the Web´s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com

Dallas, TX (PRWEB) January 24, 2013

The patient advocates at DrugRisk.com are alerting patients taking the birth control drugs Yaz or Yasmin of new information on the site showing patient claims over alleged blood clots from the drugs has now spread as far as Europe, as settlements continue in the United States.

“DrugRisk´s goal is to improve patient safety through education. By providing the public with the latest information, patients can have informed discussions with their doctors about drug side effects and decide if they need to seek the advice of a lawyer,” explains DrugRisk representative Ryan Mayer.

The resource center contains warnings from experts like the American College of Obstetricians and Gynecologists, who stated that birth control pills containing drospirenone, such as Yaz and Yasmin, may have a higher risk of causing blood clots.*

DrugRisk has also learned that thousands of patients in the U.S. have filed a Yaz lawsuit over blood clots. These have been consolidated to a special federal Multi-District Litigation court in Illinois. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).

Now, new information added to the site shows two young women in Switzerland and France have filed claims against Bayer over blood clots, prompting France´s Health Ministry to cancel reimbursements for the drugs and Switzerland´s largest health insurer to join in the claim for damages.**

DrugRisk has reported that Bayer´s most recent financial statements show the company has spent up to $750 million so far to settle around 3,500 Yaz claims, at an average of nearly $214,000 per case.*** Bayer confirmed they are only settling claims involving blood clot injuries, such as deep vein thrombosis and pulmonary embolism.

Anyone who suffered a blood clot, DVT, stroke or Pulmonary Embolism after taking Yaz or Yasmin is urged to contact the Drug Risk Resource Center or speak with a lawyer about their legal options.

The Drug Risk Resource Center cautions victims who wish to learn about their legal options that they should seek a lawyer with experience in defective drug litigation, and only recommends lawyers and law firms who have already settled Yaz lawsuits.

For more information on the research, side effects, a possible Yaz recall and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Chicago Tribune October 24, 2012, “Newer Pill has low blood clot risk: ob-gyn group”

**Reuters: “Swiss health insurer makes claim against Bayer over Yasmin pill,” January 9, 2013

***Bayer Interim Financial Statement, Legal Notes and Business Development, September 30, 2012

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebyaz-blood-clot/injuries-lawsuit/prweb10353373.htm


Source: prweb



comments powered by Disqus